mGlu5 receptor functional interactions and addiction
Author
Brown, RM; Mustafa, S; Ayoub, MA; Dodd, PR; Pfleger, KDG; Lawrence, AJDate
2012-01-01Source Title
FRONTIERS IN PHARMACOLOGYPublisher
FRONTIERS MEDIA SAAffiliation
Florey Department Of Neuroscience And Mental HealthMetadata
Show full item recordDocument Type
Journal ArticleCitations
Brown, R. M., Mustafa, S., Ayoub, M. A., Dodd, P. R., Pfleger, K. D. G. & Lawrence, A. J. (2012). mGlu5 receptor functional interactions and addiction. FRONTIERS IN PHARMACOLOGY, 3, https://doi.org/10.3389/fphar.2012.00084.Access Status
Access this item via the Open Access locationOpen Access at PMC
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345582Description
C5 - Other Refereed Contribution to Refereed Journals
Abstract
The idea of "receptor mosaics" is that proteins may form complex and dynamic networks with respect to time and composition. These have the potential to markedly expand the diversity and specificity of G protein-coupled receptors (GPCR) signaling, particularly in neural cells, where a few key receptors have been implicated in many neurological and psychiatric disorders, including addiction. Metabotropic glutamate type 5 receptors (mGlu5) can form complexes with other GPCRs, including adenosine A(2A) and dopamine D(2) receptors. mGlu5-containing complexes have been reported in the striatum, a brain region critical for mediating the rewarding and incentive motivational properties of drugs of abuse. mGlu5-containing complexes and/or downstream interactions between divergent receptors may play roles in addiction-relevant behaviors. Interactions between mGlu5 receptors and other GPCRs can regulate the rewarding and conditioned effects of drugs as well as drug-seeking behaviors. mGlu5 complexes may influence striatal function, including GABAergic output of striatopallidal neurons and glutamatergic input from corticostriatal afferents. Given their discrete localization, mGlu5-[non-mGlu5] receptor interactions and/or mGlu5-containing complexes may minimize off-target effects and thus provide a novel avenue for drug discovery. The therapeutic targeting of receptor-receptor functional interactions and/or receptor mosaics in a tissue specific or temporal manner (for example, a sub-population of receptors in a "pathological state") might reduce detrimental side effects that may otherwise impair vital brain functions.
Keywords
Pharmacology and Pharmaceutical Sciences not elsewhere classified; Health not elsewhere classifiedExport Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References